ALNYLAM PHARMACEUTICALS, INC. Increase (Decrease) in Other Accrued Liabilities
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Increase (Decrease) in Other Accrued Liabilities of $36.35 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2019-10-31
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2019-09-30 was $34.92M, a 94.21% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2019-06-30 was $16.16M, a 15.08% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2019-03-31 was -$14.73M.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2018-12-31 was $34.12M, a 33.38% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2018 was $59.36M, a 88.03% increase from fiscal 2017.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2017 was $31.57M, a 195.77% increase from fiscal 2016.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2016 was $10.67M, a 68.26% increase from fiscal 2015.
- ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for fiscal 2015 was $6.34M, a 30.46% decline from fiscal 2014.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2019-09-30 | $34.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $51.08M derived: sum of 2 quarters · filed 2019-10-31 | $36.35M 10-Q · filed 2019-10-31 | $70.46M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | $16.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.43M 10-Q · filed 2019-08-06 | $35.54M derived: sum of 3 quarters · filed 2019-08-06 | $53.52M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-03-31 | -$14.73M 10-Q · filed 2019-05-02 | $19.38M derived: sum of 2 quarters · filed 2019-05-02 | $37.37M derived: sum of 3 quarters · filed 2019-10-31 | $56.39M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-12-31 | $34.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $52.10M derived: sum of 2 quarters · filed 2019-10-31 | $71.12M derived: sum of 3 quarters · filed 2019-10-31 | $59.36M 10-K · filed 2019-02-14 |
| 2018-09-30 | $17.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $37.01M derived: sum of 2 quarters · filed 2019-10-31 | $25.24M 10-Q · filed 2019-10-31 | $50.82M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $19.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.26M 10-Q · filed 2019-08-06 | $32.84M derived: sum of 3 quarters · filed 2019-08-06 | $42.23M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$11.77M 10-Q · filed 2019-05-02 | $13.81M derived: sum of 2 quarters · filed 2019-05-02 | $23.20M derived: sum of 3 quarters · filed 2019-05-02 | $30.66M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $25.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $34.97M derived: sum of 2 quarters · filed 2019-02-14 | $42.42M derived: sum of 3 quarters · filed 2019-02-14 | $31.57M 10-K · filed 2019-02-14 |
| 2017-09-30 | $9.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $16.84M derived: sum of 2 quarters · filed 2018-11-07 | $5.99M 10-Q · filed 2018-11-07 | $9.91M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $7.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$3.40M 10-Q · filed 2018-08-02 | $520.00K derived: sum of 3 quarters · filed 2019-02-14 | $5.55M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$10.86M 10-Q · filed 2018-05-04 | -$6.93M derived: sum of 2 quarters · filed 2019-02-14 | -$1.90M derived: sum of 3 quarters · filed 2019-02-14 | $4.12M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $8.96M derived: sum of 2 quarters · filed 2019-02-14 | $14.98M derived: sum of 3 quarters · filed 2019-02-14 | $10.67M 10-K · filed 2019-02-14 |
| 2016-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $11.05M derived: sum of 2 quarters · filed 2017-11-07 | $6.75M 10-Q · filed 2017-11-07 | $17.57M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $6.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.72M 10-Q · filed 2017-08-09 | $12.54M derived: sum of 3 quarters · filed 2018-02-15 | $14.97M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | -$4.30M 10-Q · filed 2017-05-05 | $6.51M derived: sum of 2 quarters · filed 2018-02-15 | $8.95M derived: sum of 3 quarters · filed 2018-02-15 | $10.47M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $10.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $13.25M derived: sum of 2 quarters · filed 2018-02-15 | $14.78M derived: sum of 3 quarters · filed 2018-02-15 | $6.34M 10-K · filed 2018-02-15 |
| 2015-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.96M derived: sum of 2 quarters · filed 2016-11-03 | -$4.47M 10-Q · filed 2016-11-03 | -$2.64M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$6.91M 10-Q · filed 2016-08-04 | -$5.08M derived: sum of 3 quarters · filed 2017-02-15 | -$22.00K derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | -$8.43M 10-Q · filed 2016-05-04 | -$6.60M derived: sum of 2 quarters · filed 2017-02-15 | -$1.54M derived: sum of 3 quarters · filed 2017-02-15 | -$3.08M derived: sum of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $6.89M derived: sum of 2 quarters · filed 2017-02-15 | $5.35M derived: sum of 3 quarters · filed 2017-02-15 | $9.12M 10-K · filed 2017-02-15 |
| 2014-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.52M derived: sum of 2 quarters · filed 2015-11-09 | $7.29M 10-Q · filed 2015-11-09 | $4.97M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $2.23M 10-Q · filed 2015-08-07 | -$89.00K derived: sum of 3 quarters · filed 2016-02-12 | $6.83M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $3.77M 10-Q · filed 2015-05-08 | $1.45M derived: sum of 2 quarters · filed 2016-02-12 | $8.36M derived: sum of 3 quarters · filed 2016-02-12 | $7.11M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | -$2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $4.59M derived: sum of 2 quarters · filed 2016-02-12 | $3.34M derived: sum of 3 quarters · filed 2016-02-12 | $1.55M 10-K · filed 2016-02-12 |
| 2013-09-30 | $6.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $5.66M derived: sum of 2 quarters · filed 2014-11-06 | $3.87M 10-Q · filed 2014-11-06 | -$2.40M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$3.04M 10-Q · filed 2014-08-08 | -$9.31M derived: sum of 3 quarters · filed 2015-02-13 | -$9.22M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | -$1.79M 10-Q · filed 2014-05-09 | -$8.06M derived: sum of 2 quarters · filed 2015-02-13 | -$7.97M derived: sum of 3 quarters · filed 2015-02-13 | -$5.63M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | -$6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$6.18M derived: sum of 2 quarters · filed 2015-02-13 | -$3.84M derived: sum of 3 quarters · filed 2015-02-13 | -$3.59M 10-K · filed 2015-02-13 |
| 2012-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.43M derived: sum of 2 quarters · filed 2013-11-07 | $2.68M 10-Q · filed 2013-11-07 | $3.39M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.59M 10-Q · filed 2013-08-09 | $3.30M derived: sum of 3 quarters · filed 2014-02-20 | $4.13M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $252.00K 10-Q · filed 2013-05-07 | $968.00K derived: sum of 2 quarters · filed 2014-02-20 | $1.80M derived: sum of 3 quarters · filed 2014-02-20 | $929.00K derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $716.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $1.55M derived: sum of 2 quarters · filed 2014-02-20 | $677.00K derived: sum of 3 quarters · filed 2014-02-20 | $2.46M 10-K · filed 2014-02-20 |
| 2011-09-30 | $831.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$39.00K derived: sum of 2 quarters · filed 2012-11-05 | $1.74M 10-Q · filed 2012-11-05 | $1.84M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | -$870.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $910.00K 10-Q · filed 2012-08-08 | $1.01M derived: sum of 3 quarters · filed 2013-02-19 | $4.13M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $1.78M 10-Q · filed 2012-05-03 | $1.88M derived: sum of 2 quarters · filed 2013-02-19 | $5.00M derived: sum of 3 quarters · filed 2013-02-19 | $3.64M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $3.22M derived: sum of 2 quarters · filed 2013-02-19 | $1.86M derived: sum of 3 quarters · filed 2013-02-19 | $651.00K 10-K · filed 2013-02-19 |
| 2010-09-30 | $3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $1.76M derived: sum of 2 quarters · filed 2011-11-03 | $553.00K 10-Q · filed 2011-11-03 | $1.97M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$2.57M 10-Q · filed 2011-08-03 | -$1.15M derived: sum of 3 quarters · filed 2012-02-13 | -$2.71M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | -$1.21M 10-Q · filed 2011-05-05 | $212.00K derived: sum of 2 quarters · filed 2012-02-13 | -$1.35M derived: sum of 3 quarters · filed 2012-02-13 | |
| 2009-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | -$140.00K derived: sum of 2 quarters · filed 2012-02-13 | -$341.00K 10-K · filed 2012-02-13 | |
| 2009-09-30 | -$1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$1.76M 10-Q · filed 2010-11-04 | ||
| 2009-06-30 | -$201.00K 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | -$3.82M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |